LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
Article Details
- CitationCopy to clipboard
Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG
LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
Cancer Cell. 2007 Sep;12(3):239-51.
- PubMed ID
- 17785205 [ View in PubMed]
- Abstract
LZAP has been reported to inhibit cellular proliferation and clonogenic growth. Here, we report that decreased LZAP expression promoted cellular transformation, xenograft tumor growth, and xenograft tumor vascularity. Loss of LZAP also increased cellular invasion, and MMP-9 expression dependent on NF-kappaB. LZAP directly bound to RelA, impaired serine 536 phosphorylation of RelA, increased HDAC association with RelA, inhibited basal and stimulated NF-kappaB transcriptional activity, and was found at the promoter of selective NF-kappaB-responsive genes. LZAP protein levels were markedly decreased in 32% of primary HNSCCs (n = 28) and decreased LZAP levels in primary HNSCC correlated with increased expression of the NF-kappaB-regulated genes IL-8 and IkappaBalpha. In aggregate, these data support a role of LZAP in NF-kappaB regulation and tumor suppression.